Margareta Linden
Corporate Officer/Principal at University of Lund
Profile
Margareta Linden has been Senior Director of Project Planning and Development for Camurus AB since March 2004 and an Associate Professor of Experimental Respiratory Medicine at Lund University since 1993.
Previously, she held various positions at AstraZeneca AB.
Dr. Linden has more than 20 years of R&D and project management experience in the pharmaceutical industry.
She received a BS degree and a PhD from Lund University.
Margareta Linden active positions
| Companies | Position | Start |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 31/12/1992 |
Former positions of Margareta Linden
| Companies | Position | End |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
| CAMURUS AB | Corporate Officer/Principal | - |
Training of Margareta Linden
| University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CAMURUS AB | Health Technology |
| Private companies | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Margareta Linden
